TABLE 3.

Posttransplant mortality and causes of death among obese liver transplant recipients (including patients transplanted from 2000 to present)

Study, year	Study period	Total (N)	BMI categories (kg/m2), n	Mortality rates	P
Hillingso et al, 200534	1990–2002	40	BMI, < 30: n = 20	65% (13/20)	0.01
			BMI, > 30: n = 20	30% (6/20)
Fujikawa et al, 200636	1990–2005	700		1 y patient survival
			BMI, < 25: n = 288	82%	NS
			BMI, 25–30: n = 245	87%	NS
			BMI, ≥ 30: n = 167	86%	NS
			BMI, ≥ 35: n = 37	n/a)	NS
				5 y patient survival
			BMI, < 25: n = 288	67%	NS
			BMI, 25–30: n = 245	73%	NS
			BMI, ≥ 30: n = 167	71%	NS
			BMI, ≥ 35: n = 37	n/a	NS
Pelletier et al, 200728	2001–2004	4488		HR
			BMI, <20: n = 181	1.28	0.15
			BMI, 20 to <25: n = 1161	1.00 (reference)	Ref
			BMI, 25 to <30: n = 1648	0.92	0.35
			BMI, 30 to <35: n = 944	0.84	0.10
			BMI, 35 to <40: n = 402	1.04	0.78
			BMI, ≥ 40: n = 152	1.16	0.43
Leonard et al, 20085	1998–2006	1313	Corrected for ascites	1 y Mortality—11%	0.79
		NIDDK - 704	BMI, <18: n = 67	11%
		Mayo - 609	BMI, 18.5–25: n = 561	11%
			BMI, 25.1–30: n = 405	11%
			BMI, 30.1–35: n = 178	8%
			BMI, 35.1–40: n = 69	10%
			BMI, >40: n = 33	3%
				5 y Mortality—31%	0.79
			BMI, <18: n = 67	31%
			BMI, 18.5–25: n = 561	20%
			BMI, 25.1–30: n = 405	23%
			BMI, 30.1–35: n = 178	12%
			BMI, 35.1–40: n = 69	18%
			BMI, >40: n = 33	20
Dick et al, 200958	1987–2007	71 446	BMI, 18.5 to <40: n = 68 172	36%	0.02
			BMI, ≥40: n = 1447	39%
Bambha et al, 20154	2002–2011	45 551:		Mortality 1 y post-LT	NS
			BMI, 18.5 to 24.9: n = 13262	12%
			BMI, 25–29.9: n = 16329	11%
			BMI, 30 to 34.9: n = 9639	11%
			BMI, 35–39.9: n = 4062	12%
			BMI, ≥40: n = 1396	12%
Saab et al, 201459	1990–2013	74 487	BMI, <30: n = 72 212		0.66
			BMI, >30: n = 2275
Schlansky et al, 201630	2005–2014	80 221		5 y Mortality
			BMI,< 30: n = 49 969	21.2%	0.45
			BMI, 30–35: n = 18 793	20.5%
			BMI, 35.1–40: n = 8.356	21.5%
			BMI, ≥40: n = 3103	21%